Brief: inTEST To Restate Third Quarter And First Nine Months 2023 Financial Statements

inTest

12/03/2024 21:11

March 12 (Reuters) - inTest Corp  INTT.A :
    * INTEST TO RESTATE THIRD QUARTER AND FIRST NINE MONTHS 2023
FINANCIAL STATEMENTS
    * INTEST CORP: PLANS TO RESTATE ITS PREVIOUSLY ISSUED
CONSOLIDATED
FINANCIAL STATEMENTS FOR Q3 AND NINE MONTHS ENDED SEPTEMBER 30,
2023
    * INTEST CORP: PRELIMINARY INDICATIONS ARE THAT Q3 2023
RESTATEMENT IS EXPECTED TO RESULT IN A DECREASE IN REVENUE OF
ABOUT$1.7 MILLION
    * INTEST CORP: NET INCOME IS EXPECTED TO BE APPROXIMATELY
$700,000
LOWER FOR Q3 2023
    * INTEST CORP: EARNINGS PER DILUTED SHARE FOR Q3 2023 AS
PREVIOUSLY REPORTED IS EXPECTED TO BE REDUCED FROM $0.24 TO
$0.19
    * INTEST CORP: DEFERRAL OF REVENUE IS ALSO EXPECTED TO HAVE
A
SMALL IMPACT ON PREVIOUSLY ANNOUNCED PRELIMINARY Q4 RESULTS
    * INTEST CORP: Q4 2023 REVENUE IS NOW EXPECTED TO BE
APPROXIMATELY
$27.9 MILLION WITH NET EARNINGS OF $1.5 MILLION, OR $0.12 PER
DILUTED SHARE
    * INTEST CORP: INTENDS TO AMEND AND FILE ITS Q3 2023 10-Q/A
AS
SOON AS PRACTICAL
    * INTEST CORP: INVESTORS SHOULD NO LONGER RELY UPON
COMPANY'S
PREVIOUSLY RELEASED FINANCIAL STATEMENTS FOR Q3 AND NINE MONTHS
ENDED SEPTEMBER 30, 2023
    * INTEST CORP: PRELIMINARY RESULTS REPORTED FOR Q4 ENDED
DECEMBER
31, 2023, SHOULD NO LONGER BE RELIED UPON

Source text for Eikon:  ID:nBw9vfZ3Xa 
Further company coverage:  INTT.A 

 ((Reuters.Briefs@thomsonreuters.com;))